---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-23-050508"
form_type: "8-K"
ticker: null
cik: "0001708331"
company_name: "Virpax Pharmaceuticals, Inc."
filed_at: "2023-06-21T23:59:59+00:00"
generated_at: "2026-06-13T20:07:23.962207+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Virpax (VRPX) names Vinay Shah CFO; Christopher Chipman resigns

## Summary
- Vinay Shah appointed CFO effective June 20, 2023, succeeding Christopher Chipman who resigned to pursue other opportunities.
- Shah's base salary $312,000; target bonus 30% of base; option to purchase 100,000 shares vesting over 4 years.
- Chipman's separation: $234,000 severance in 4 monthly installments of $58,500; COBRA for 4 months; accelerated option vesting.
- Chipman's resignation not due to any disagreement with the company on operations, policies, or accounting.
- Shah previously served as CFO of Aravive and held finance roles at Pacira Pharmaceuticals; over 30 years of experience.

## SEC filing metadata
- accession: 0001213900-23-050508
- form_type: 8-K
- cik: 0001708331
- company_name: Virpax Pharmaceuticals, Inc.
- filed_at: 2023-06-21T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1708331/000121390023050508/0001213900-23-050508-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1708331/000121390023050508/ea180640-8k_virpaxpharm.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-23-050508
- JSON: https://secwatch.observer/filing/0001213900-23-050508.json
- Plain text: https://secwatch.observer/filing/0001213900-23-050508.txt

## Key facts
- Executive change
  Christopher Chipman resigned as Chief Financial Officer at Virpax Pharmaceuticals, Inc..
  - Action: resigned
  - Role: Chief Financial Officer
  source text: On June 18, 2023, Christopher Chipman notified the Chairman of the Board of Directors of the Company of his decision to resign from his position as the Company’s Chief Financial Officer to pursue other opportunities.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1708331/000121390023050508/0001213900-23-050508-index.htm
- Executive change
  Vinay Shah was appointed as Chief Financial Officer at Virpax Pharmaceuticals, Inc..
  - Action: appointed
  - Role: Chief Financial Officer
  source text: Effective as of June 20, 2023, the Board of Directors of Virpax Pharmaceuticals, Inc. (the “Company”) appointed Vinay Shah to serve as the Company’s Chief Financial Officer.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1708331/000121390023050508/0001213900-23-050508-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.